4//SEC Filing
Klassen Preston 4
Accession 0000950170-24-062921
CIK 0001505512other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:22 PM ET
Size
5.3 KB
Accession
0000950170-24-062921
Insider Transaction Report
Form 4
Klassen Preston
DirectorPresident & Head of R & D
Transactions
- Award
Stock Option (Right to Buy)
2024-05-20+528,000→ 528,000 totalExercise: $2.01Exp: 2034-05-19→ Common Stock (528,000 underlying)
Footnotes (1)
- [F1]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001493056
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:22 PM ET
- Size
- 5.3 KB